BT
ARKG icon

Banque Transatlantique’s ARK Genomic Revolution ETF ARKG Stock Holding History

Banque Transatlantique’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$8.63K Hold
326
– – ﹤0.01% 381
2025
Q4 		$9.51K Hold
326
– – ﹤0.01% 209
2025
Q3 		$9.08K Hold
326
– – ﹤0.01% 214
2025
Q2 		$7.93K Buy
+326
New +$7.14K ﹤0.01% 207
2025
Q1 		– Sell
-326
Closed -$7.68K – 236
2024
Q4 		$7.68K Buy
+326
New +$8.02K ﹤0.01% 224

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Banque Transatlantique's ARKG Position: Q1 2026 in Review

Banque Transatlantique held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 326 shares worth $8.63K. The position accounts for ﹤0.01% of the portfolio, ranked #381.

Banque Transatlantique first reported a position in ARKG in Q4 2024 and has held it in 5 quarters since. The position peaked at $9.51K in Q4 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Banque Transatlantique held 326 shares of ARK Genomic Revolution ETF worth $8.63K as of Q1 2026.
  • Banque Transatlantique left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Banque Transatlantique's portfolio in Q1 2026, its #381 holding.
  • Banque Transatlantique first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 5 quarters since.
  • Banque Transatlantique's ARK Genomic Revolution ETF position peaked at $9.51K in Q4 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Banque Transatlantique's 13F filing for Q1 2026, filed 13 May 2026.